Suppression of isoprenylcysteine carboxylmethyltransferase compromises DNA damage repair
Open Access
- 5 October 2021
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 4 (12), e202101144
- https://doi.org/10.26508/lsa.202101144
Abstract
DNA damage is a double-edged sword for cancer cells. On the one hand, DNA damage–induced genomic instability contributes to cancer development; on the other hand, accumulating damage compromises proliferation and survival of cancer cells. Understanding the key regulators of DNA damage repair machinery would benefit the development of cancer therapies that induce DNA damage and apoptosis. In this study, we found that isoprenylcysteine carboxylmethyltransferase (ICMT), a posttranslational modification enzyme, plays an important role in DNA damage repair. We found that ICMT suppression consistently reduces the activity of MAPK signaling, which compromises the expression of key proteins in the DNA damage repair machinery. The ensuing accumulation of DNA damage leads to cell cycle arrest and apoptosis in multiple breast cancer cells. Interestingly, these observations are more pronounced in cells grown under anchorage-independent conditions or grown in vivo. Consistent with the negative impact on DNA repair, ICMT inhibition transforms the cancer cells into a “BRCA-like” state, hence sensitizing cancer cells to the treatment of PARP inhibitor and other DNA damage–inducing agents.Funding Information
- Ministry of Education of Singapore and National Medical Research Council Individual (MOE2017-T2-1-039, NMRC/CIRG/1486/2018)
This publication has 102 references indexed in Scilit:
- Rare Mutations in XRCC2 Increase the Risk of Breast CancerAmerican Journal of Human Genetics, 2012
- MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair SignalsMolecular Cancer Therapeutics, 2011
- The XPA-binding domain of ERCC1 Is Required for Nucleotide Excision Repair but Not Other DNA Repair PathwaysOnline Journal of Public Health Informatics, 2010
- Cells deficient in PARP-1 show an accelerated accumulation of DNA single strand breaks, but not AP sites, over the PARP-1-proficient cells exposed to MMSMutation research. Reviews in mutation research, 2009
- PARP inhibitors and the treatment of breast cancer: beyond BRCA1/2?Breast Cancer Research, 2009
- Single-Stranded DNA Orchestrates an ATM-to-ATR Switch at DNA BreaksMolecular Cell, 2009
- Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cellsBlood, 2008
- Inactivating Icmt ameliorates K-RAS–induced myeloproliferative diseaseBlood, 2008
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle ProgressionCell, 2008
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005